Cardiovascular Disease Clinical Trial
— DESHOfficial title:
Improving Use of Evidence in Policy: District Evaluation Study on Health
The purpose of this study is to assess the impact of disseminating information on comparative performance, along with actionable messages on how to improve health outcomes, to district-level decision-makers in India using a randomized, controlled design. This information should improve prioritization of health services by district health officers, budget allocation for health, and implementation of priority health services at the district level.
Status | Active, not recruiting |
Enrollment | 594 |
Est. completion date | July 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria (Districts): - All districts in India in existence in 2001 Exclusion Criteria (Districts): - All districts in India created after 2001 Inclusion Criteria (District Officials): - Members of Parliament (MPs) who sit in the Lok Sabha (Lower House of Parliament) and represent constituencies that are contained within or overlap study districts - Members of Legislative Assembly (MLAs) who represent constituencies that are contained within study districts - District Collectors (DCs) who administrate study districts - Zilla Parishad Chief Executive Officers (ZPCEOs) who administrate study districts - District Health Officers (DHOs) who work in study districts Exclusion Criteria (District Officials): - MPs who sit in the Rajya Sabha (Upper House of Parliament), Lok Sabha MPs who represent constituencies not contained within or overlapping study districts, Lok Sabha MPs who represent constituencies that overlap both experimental and control study districts - MLAs who represent constituencies not contained within study districts - DCs who administrate non-study districts - ZPCEOs who administrate non-study districts - DHOs who work in non-study districts |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Canada | Centre for Global Health Research, St. Michael's Hospital | Toronto | Ontario |
India | St. John's Research Institute | Bangalore | Karnataka |
Lead Sponsor | Collaborator |
---|---|
St. Michael's Hospital, Toronto | Canadian International Development Agency, Lombard Insurance Global Poverty Action Lab, St. John's Research Institute |
Canada, India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Differences in any of primary and secondary outcomes between Empowered Action Group and Assam (EAGA) states and non-EAGA states | Five years | No | |
Other | Differences in any of primary and secondary outcomes between measles-focus states and non-measles-focus states | Five years | No | |
Primary | Percentage children 12-23 months vaccinated against measles | Five years | No | |
Primary | Percentage children <3 yrs with diarrhea in past 2 weeks given oral rehydration solution | Five years | No | |
Primary | Percentage facility-based births for the last child since 2007 | Five years | No | |
Secondary | Percentage last child >3 yrs breast fed within 1 hr of birth | Five years | No | |
Secondary | Percentage women given advice on breastfeeding and newborn thermal care during antenatal care | Five years | No | |
Secondary | Percentage subcenters with oral rehydration solution available on day of survey and no stockouts for more than 10 days in last month | Five years | No | |
Secondary | Percentage community health centres with at least 1 surgeon or ob/gyn | Five years | No | |
Secondary | Percentage public health centres with reagents, light microscope and lab technician for malaria blood smear | Five years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|